Delivery Order SPE2DB20D2014-SPE2DB25FC85S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product, with final completion scheduled for August 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XDEMVY 0.25% Drop in a 10 mL formulation, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml quantities under a firm fixed price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for pharmaceutical supplies valued at $1,223.59. The contract covers XDEMVY 0.25% DROP 10ML, a specialized pharmaceutical product, with an ultimate completion date of August 27, 2025. The award was made through a competitive process with no set-aside designation and utilizes firm fixed pricing. This delivery order will be fulfilled at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,223.59. This firm fixed-price delivery order, issued on September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-competitive with no set-aside designation and...
- This delivery order, valued at $1,223.59, was awarded on July 23, 2025, to AmerisourceBergen Drug Corp for the supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. The contract represents a firm fixed price delivery order under a competitive, non-set-aside procurement process. Performance will be completed by August 13, 2025, with fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. The Defense Logistics Agency, through...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of XDEMVY 0.25% drop in 10ml quantities, with a ceiling value of $1,223.59 and a firm fixed price structure. This non-set-aside competitive award is categorized as a delivery order with an ultimate completion date of September 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. The contract utilizes firm fixed pricing and carries a completion date of October 6, 2025. This non-set-aside award was competitively awarded and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of XDEMVY 0.25% drop in 10 ml quantities, with a ceiling value of $1,223.59. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and carries an ultimate completion date of May 15, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, serving as the place of performance. As a child contract vehicle,...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC85SDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 27, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,223.59. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This delivery order is issued under AmerisourceBergen's comprehensive pharmaceutical prime vendor global support vehicle with the Defense Logistics Agency, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms. The company's federal contract portfolio demonstrates consistent capability in fulfilling competitive federal medical supply requirements across multiple therapeutic domains, from specialty medications to medical devices and vaccines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/27/25 |